Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Paratek Pharma Inc (NQ: PRTK )

2.120 -0.020 (-0.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,924,800
Open 2.180
Bid (Size) 1.950 (2)
Ask (Size) 2.140 (2)
Prev. Close 2.140
Today's Range 2.040 - 2.300
52wk Range 1.600 - 7.450
Shares Outstanding 52,366,173
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga

Performance

YTD
-53.91%
-53.91%
1 Month
+22.54%
+22.54%
3 Month
-30.94%
-30.94%
6 Month
-52.78%
-52.78%
1 Year
-70.92%
-70.92%

More News

Read More
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Via Benzinga
Paratek Pharmaceuticals' Shares Gain Following FDA Fast Track Designation For Nontuberculous Mycobacterial (NTM) Drug
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Earnings Outlook For Paratek Pharmaceuticals
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Paratek Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Earnings Scheduled For March 14, 2022
Via Benzinga
Paratek Pharmaceuticals's Earnings: A Preview
Via Benzinga
The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
Via Benzinga
Week In Review: BeiGene Completes $3.5 Billion IPO On Shanghai STAR Board
Via Talk Markets
Zai Lab's Nuzyra Approved In China For Bacterial Infections
Via Benzinga
Recap: Paratek Pharmaceuticals Q3 Earnings
Via Benzinga
Paratek Pharmaceuticals's Return On Capital Employed Insights
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Paratek Secures BARDA Funding To Develop Nuzyra Antibiotic For Pulmonary Anthrax
Via Benzinga
Earnings Scheduled For November 8, 2021
Via Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.